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Abstract
The HMO Research Network (HMORN) Virtual Data Warehouse (VDW) is a public, non-proprietary,
research-focused data model implemented at 17 health care systems across theUnited States. The HMORN
has created a governance structure and specified policies concerning the VDW’s content, development,
implementation, and quality assurance. Data extracted from the VDW have been used by thousands of studies
published in peer-reviewed journal articles. Advances in software supporting care delivery and claims
processing and the availability of new data sources have greatly expanded the data available for research, but
substantially increased the complexity of data management. The VDW data model incorporates software and
data advances to ensure that comprehensive, up-to-date data of known quality are available for research. VDW
governance works to accommodate new data and system complexities. This article highlights the HMORN
VDW data model, its governance principles, data content, and quality assurance procedures. Our goal is to
share the VDW data model and its operations to those wishing to implement a distributed interoperable
health care data system.
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Introduction
The HMO Research Network (HMORN) Virtual Data Warehouse 
(VDW) removes duplicative work within a research center by 
maintaining single extract, transform, and load (ETL) processes for 
creating commonly used variables in single and multisite research 
studies. This allows research projects to focus data development 
efforts on data not yet included in the VDW. By documenting 
these pioneering efforts and following VDW documentation 
guidelines, investigators contribute to expanding VDW coverage. 
Other projects and other research centers can build on the work of 
individual projects to expand the VDW data model. Because VDW 
data files already exist at each site, data query tools may be used 
to obtain preparation-to-research data tabulations across multiple 
sites within days or even hours. Such queries enable investigators to 
expediently assess the feasibility of research questions and quickly 
compute statistical power levels. Implementing the VDW data 
model supports efficient data warehousing and analytic efforts on 
research projects from feasibility through final analysis.
Population-based health care research requires comprehensive, high 
quality data on large and diverse cohorts. Collecting these compre-
hensive data specifically for research purposes can be costly, even for 
relatively small numbers of individuals. To collect data efficiently on 
large populations, scientists frequently rely on information routine-
ly collected in the course of delivering health care and generating 
bills and health insurance claims. These operational data systems 
and models, however, are not designed for research. For example, 
a claims adjudication system might organize its data to link insur-
ance contract information with the services billed by health care 
providers. An electronic health record (EHR) might organize and 
store data in a way that facilitates the rapid display of all information 
about a particular patient to meet the needs of a clinician. For these 
reasons, data structures that support claims adjudication software 
or an EHR are often not conducive to population-level queries, for 
example assessing changes in blood pressure across all incident users 
of a therapeutic drug for a pharmacoepidemiology study. Special 
procedures and expertise are needed to create research-quality data 
from operational insurance and clinical data.
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To repurpose clinical, administrative, and claims data for research 
use, scientists must design data models specifically to facilitate 
research and then extract, transform, and load data from source 
systems to a research data model (Figure 1). The data model design 
and ETL process can be labor intensive and prone to error due to 
data system complexity and frequently changing data sources. Fre-
quently, these ETL processes are performed on a project-by-project 
basis, which exacerbates cross-project inconsistency and duplicates 
costly programming. As demand for these project-specific research 
data sets has grown, research institutions have invested in research 
data warehouses and technical infrastructure that standardize their 
data extraction processes.1-4 This approach has several advantag-
es. By identifying common data needs across research projects, the 
data model design and initial ETL processes can be done once and 
maintained centrally. Having many users of the same data warehouse 
greatly increases opportunities to develop analytic efficiencies and 
identify, document, and resolve quality issues, thereby benefiting both 
current and future projects. A research data warehouse enables a re-
search center to develop its data assets strategically and intentionally.
A research data model also enables the development of tools and 
resources that can be used across projects over time. For example, 
algorithms that define common research concepts such as “med-
ication adherence,” “type 2 diabetic patients,” “high-deductible 
medical insurance,” and “comorbidity index” can be created once 
and shared across projects. In addition, the standardized and stable 
data model facilitates the development of software tools, and stan-
dardized querying approaches can make use of the shared resource.
Unfortunately, even the largest health-plan data warehouses are often 
insufficient to address many research questions. To address this lim-
itation, multicenter collaborations are formed to aggregate data across 
institutions to obtain larger and more representative populations.5 
Consortia such as the Centers for Disease Control and Prevention’s 
(CDC) Vaccine Safety Datalink (VSD),6 the Agency for Healthcare 
Research and Quality (AHRQ) Centers for Education and Research on 
Therapeutics (CERT),7 the National Heart Lung and Blood Institute’s 
(NHLBI) Cardiovascular Research Network,8 and the National Cancer 
Institute (NCI) Cancer Research Network (CRN)9 have designed data 
models, infrastructure, and governance that allow data aggregation 
across institutions for research purposes while ensuring that health 
care organizations maintain local control over their highly regulated 
and proprietary data.10-12 Aggregating data across multiple and diverse 
health care organizations and systems increases the generalizability of 
research findings. By covering a greater population, aggregating data 
provides greater ability to study rare exposures and outcomes, conduct 
subgroup analyses, and improve statistical power.
In this article, we describe the development and governance of one 
such distributed data model, the HMORN VDW. The HMORN 
is an international consortium of 18 health care delivery systems 
with public domain research programs; 17 members use the VDW 
data model to support multicenter research (http://www.hmore-
searchnetwork.org).13-15 HMORN VDW data are used for studies 
on a broad range of topics in health services research and epidemi-
ology, in observational studies and clinical trials.16-21 We describe 
the principles that guide VDW development and the policies that 
result from those principles. Finally, we describe how these policies 
are put into practice through the VDW’s many uses.
Approach to the Model
Principles
At inception, the HMORN VDW data model did not establish a 
set of principles to govern its development. The NCI CRN founded 
the VDW to achieve its study aims. These principles were formed 
organically while the CRN worked through challenges in data 
provenance, data governance, and regulations. While never having 
been codified in bylaws, the HMORN VDW data model adheres to 
the following principles:
The first principle of the HMORN VDW is that its primary 
purpose is to facilitate public domain health and health services 
research. A consequence of this principle is that the data model 
does not always conform to common relational database theory 
such as database normalization or enforced key constraints. When 
database theory and pragmatism are at odds during data model 
development or implementation, the practical solution is favored. 
For example, the VDW at times contains redundant data to expe-
dite the extraction of large volumes of data, despite the risk of data 
inconsistency within the model. 
A second principle is that the VDW, its tools, and governance 
policies should facilitate compliance with human subjects pro-
tection and privacy regulations as well as proprietary institu-
tional interests. This principle compels us to implement the VDW 
as a federated database in which data reside locally at their respec-
tive institutions until the point of extraction for a specific approved 
purpose. Data extraction for research occurs only after Institu-
tional Review Board (IRB) approval, and the transfer of protected 
health information among institutions occurs only after data use 
agreements (DUA) or other contractual agreements are execut-
ed. Tools and applications built on the VDW data model must 
consider these restrictions in their interactions with and use of the 
data. For instance, the HMORN has developed a tool that identifies 
VDW
Care Delivery & Health 
Plan Data Systems Various ETL 
processes
VDW data 
remains at sites
HMORN
Parent Organizations
HMORN
Research Organizations
Multisite
Project Team
VDW
VDW
Extraction of Limited or 
'HLGHQWLÀHG'DWD
QA Feedback
Site A
Site B
Site C
Data are generated in the course of care delivery and health plan administration.  Each site transforms these data 
according to the standard VDW data model. Researchers extract data from the VDW and provide feedback to 
improve data quality.
Figure 1. Data Flow in and out of the VDW
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possible protected health information among queried VDW data 
and prompts data stewards to reconcile the data to be shared with 
applicable DUAs before transfer.22
A third principle of the VDW is that the data model is public 
and nonproprietary, although the data contained within the 
model are not. Any entity may implement the HMORN VDW or 
clone and adapt the model to serve its particular need. The U.S. 
Food and Drug Administration Mini-Sentinel Network initiative,23 
for example, modified the VDW model to develop the Mini-Senti-
nel Common Data Model for medical product safety surveillance. 
Increasingly, health systems that implement the VDW initially 
for research purposes are making use of the VDW for internal 
business reporting and decision support rather than modifying 
the model for their particular use. A consequence of this principle, 
however, is that the VDW cannot replicate specifications from pro-
prietary data models or publish proprietary medical terminology.
A fourth principle is that the VDW data model should be 
flexible and extensible to accommodate a range of participating 
institutions, research interests, and data sources. As new insti-
tutions with different data environments implement the VDW, 
the governing body modifies specifications to integrate the new 
data. As an example, the addition of health care organizations not 
integrated with health plans meant broadening study definitions 
that determine populations at risk for an outcome or exposure. 
Previously, “at risk” was defined strictly as a person enrolled in a 
health care plan. Once the HMORN added new organizations, we 
changed this conception to include people based on their place of 
residence or by patterns of health care utilization. To accommo-
date the broadest range of research interests possible, the VDW 
data model covers a variety of content areas. Its design also allows 
researchers to supplement VDW data with narrower content-spe-
cific data sources. For instance, studies by the National Institute of 
Mental Health’s Mental Health Research Network (MHRN)24 use 
data on diagnoses, procedures, and pharmaceutical dispensings 
from the VDW; however, data on patient responses to the PHQ9 
depression screening instrument25 are not currently in the VDW. 
The VDW design allows MHRN investigators to collect these data 
separately and easily merge them with VDW data. Supplemented 
data likely to be used repeatedly can be incorporated as new data 
tables into the VDW model.
A fifth principle of the VDW is that the data model should be 
agnostic to source data systems. In practice, this means that VDW 
specifications are defined by data concepts rather than data sources. 
For example, the VDW defines race and ethnicity categories in 
accordance with National Institute of Health policy26 rather than 
any data source system that collects race. Further, while replicating 
a data model specification that imitates a data source shared across 
multiple institutions might be expedient, this impairs other insti-
tutions from contributing data. Imitating source data models also 
potentially violates the third principle of the VDW as a public data 
model if the source data model is proprietary. For these reasons, the 
VDW data model is agnostic to source.
In summary, these five principles have led to a data sharing model 
that is tailored to the needs of researchers, protects the privacy 
and confidentiality of member data, can encompass new content 
areas, and facilitates aggregation of data across disparate health 
care delivery systems.
Policies and Governance
The HMORN VDW Operations Committee (VOC) (Figure 2) is 
the governing body responsible for VDW development, imple-
mentation, operations, and oversight. Workgroups under the 
VOC, each co-led by a scientist and a data programmer, conduct 
quality assurance, develop specification changes, and support 
implementation for specific content areas. VOC membership con-
sists of workgroup leads and representatives from multisite con-
sortia such as the MHRN, VSD, CVRN, Mini-Sentinel, and CRN. 
The VDW Implementation Group (VIG) consists of the work-
group leads as well as site data managers who are chiefly respon-
sible for implementing the VDW at their respective institutions. 
The VOC, VIG, and workgroups each have monthly teleconfer-
ence meetings. The VIG additionally has two in-person work-
ing meetings per year. VDW oversight is provided by the Asset 
Stewardship Committee (ASC) whose members include research 
center directors, investigators, and senior staff who develop and 
maintain tools useful for multiorganizational research in areas 
such as data development, procedures for human subjects review, 
and administrative efficiencies. The ASC in turn is overseen by 
the HMORN Governing Board, which consists of the directors of 
the participating research institutions and provides leadership and 
strategic direction to the HMORN.
Formalized processes exist for changing VDW specifications, 
implementing new VDW tables, and formulating new work-
groups. These activities can be costly for VDW implementers and 
tool builders, so specification changes and table additions are 
first proposed by workgroups, then discussed by the VIG. Formal 
approval is by vote, frequently at in-person meetings. Each change 
to a VDW table results in an incremented table version number. 
VDW specifications are published on a public website,27 while 
meeting minutes, implementation documentation, and HMORN 
policies are hosted on a private website. Data quality issues, 
identified either by VDW users or through dedicated quality 
assurance programs, are logged in an issue tracker viewable by 
HMORN members and collaborators and reviewed monthly at 
VIG meetings.
Quality Assurance
VDW data quality is assessed and improved through two mech-
anisms: dedicated quality assurance programming and crowd-
sourcing via the VDW user base. Workgroups are responsible for 
authoring quality assurance programs that assess adherence to 
the VDW data model and identify data anomalies. These quality 
checks range from simply verifying the existence of variables and 
assuring they contain only permissible values to more sophisticat-
ed analyses requiring clinical or scientific knowledge such as com-
paring rates and trends of events across institutions. Identified 
3
Ross et al.: The HMO Research Network Virtual Data Warehouse:  A Public Data Model to Support Collaboration
Produced by The Berkeley Electronic Press, 2014
eGEMs
data anomalies can be the result of errors in ETL code, limitations 
in data availability from source systems at an institution, or true 
anomalies in the data.
Studies and research consortia that use the VDW are encouraged 
to begin their data analysis with basic descriptive assessments of 
variables key to their research. The prolific use of the VDW ensures 
that this crowdsourced quality assurance approach identifies most 
discovered data anomalies. This approach also prioritizes quality 
assessment based on the most commonly used variables. Quality 
assurance by users who are experts in their field means that eval-
uation is by the people who are most likely to identify data issues. 
Kaiser Permanente’s Center for Effectiveness and Safety Research 
(CESR)28 is an example of a consortium that has conducted exten-
sive quality analysis on VDW data across participating sites and 
shared these programs with the VOC workgroups. Data anomalies, 
whether identified by VDW workgroups or users, are recorded in 
an issue tracking system on a private website. Site data managers 
investigate anomalies and report resolutions in the issue tracker. 
This critical knowledge management process helps prevent scientif-
ic errors and the inefficient use of study resources to reidentify data 
anomalies already discovered by prior researchers.
Application of the Model
Content of the VDW Data Model
The VDW data model (Figure 3) has seven content areas: enroll-
ment/demographics, utilization, laboratory, pharmacy, census, 
tumor registry, and vital signs/social history. These content areas 
comprise more than 450 variables among 18 tables. Variable avail-
ability is dependent on collection and preservation of data in local 
source data systems. Site data managers document the availability 
and missingness of data on a shared secure web portal as a part of 
VDW implementation. A rich set of tools, applications, and data 
models have successfully interfaced with the VDW. PopMedNet, 
an open-source distributed querying software application (http://
www.popmednet.org), includes several query tools that operate 
against the VDW and is being used by several HMORN sites for 
general feasibility queries and by several HMORN-based proj-
ects to enable distributed querying. Installations of Informatics 
for Integrating Biology and the Bedside (i2b2, https://www.
i2b2.org) software, a data warehouse and associated querying 
tool, have been established at select sites with data drawn from 
the VDW to facilitate proposed research project feasibility. The 
Mini-Sentinel Common Data Model is derived from the VDW 
data model through maintained ETL code that translates the 
VDW to the Mini-Sentinel data model. The VSD data model, with 
the exceptions of its mother-baby linkage and dedicated vaccine 
tables, may also be derived from the VDW. The VOC maintains 
a library of publicly available SAS macros (https://github.com/
HMORN/vdw-macros) called “Standard Macros,” for users to 
perform common research tasks such as identifying individuals 
continuously at risk for outcomes or exposures, calculating body 
mass index percentiles for children, and calculating comorbidity 
scores. The VOC also maintains a dictionary of references, called 
“Standard Vars,” which simplifies data extraction by abstracting 
away site-specific environmental factors like directory names and 
database connection strings.
Context Among Other Data Models
The HMORN VDW is just one standardized data model cur-
rently used in clinical research.6,23,29,30 Other standardized mod-
els include the Vaccine Safety Datalink, Observational Medical 
Outcomes Partnership (OMOP), and the Mini-Sentinel Common 
Data Model. The i2b2 is a commonly used data repository, but 
it does not enforce standard value sets; each implementation of 
i2b2 can by definition be unique, whereas each implementation 
of the other data models mentioned are intended to be compara-
ble. These standardized data models were not developed inde-
pendently, but rather were built on shared and learned processes, 
data concepts, and best practices. Differentiation among models 
exists principally because of their different users, the needs of the 
funders/organizer, and characteristics of the expected data con-
tributors. The HMORN VDW’s first principle is that it exists to 
facilitate public research by a large cohort of investigators across 
a wide range of clinical areas and research topics, ranging from 
comparative effectiveness and safety research to epidemiology to 
burden of illness. The VDW guiding principles also placed a high 
priority on analytic simplicity and data provenance (see princi-
ples section above). The Vaccine Safety Datalink data model is 
based on similar source data as the VDW but, in contrast, serves 
to support prospective near-real-time vaccine safety monitoring 
and therefore has developed a unique approach to organizing and 
using the data to support that mission. Mini-Sentinel’s Common 
Data Model is a simplified derivative of the HMORN VDW 
designed specifically to support medical product safety surveil-
lance for the U.S. Food and Drug Administration. The OMOP 
data model borrowed lessons from the VDW and developed its 
own model to support high-throughput methodologic research 
on comparative safety and effectiveness, with a specific need to 
accommodate medical data from a diverse range of data sources 
to enable comparisons across those disparate data types.
Other Committees
(e.g., Administration)
The VDW Operations Committee (VOC) is the governing body responsible for the VDW.  Workgroups under the VOC are responsible for 
VSHFLÀFGDWDFRQWHQWDUHDV The Asset Stewardship Committee and HMORN Governing Board provide oversight over HMORN resources 
including the VDW.  The VDW Implementation Group includes site data managers who implement the VDW at their respective site.
Governing Board
Asset Stewardship 
Committee
VDW Operations 
Committee (VOC)
VDW 
Implementation 
Group (VIG)
Utilization
Enrollment & 
Demographics
LabPharmacy
Tumor Census
Vital Signs
Data Content Area Workgroups
Ad hoc 
Workgroups
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Figure 2. HMORN Governance
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Moody and Shank31 created a framework to evaluate data models 
that can be used to compare data model quality dimensions. While 
all dimensions are important in this framework and comparisons 
are difficult to make out of specific use case contexts, the HMORN 
VDW tends to have more complete data but less simplicity, so as 
to accommodate the broader set of expected uses. Flexibility, or 
what we have termed “extensibility,” has greater emphasis than does 
correctness. Integrity, implementability, and integration are more 
critical than understandability. These emphases guide the VDW’s 
development in contrasting ways to other clinical data models.
Implementation and Use
The HMORN VDW currently consists of 17 sites that together cover 13 
million individuals; in total, the VDW has over 185 million person-years 
of data. Additional non-HMORN affiliated institutions in the Denver 
metropolitan area are currently implementing their own VDW nodes 
to promote federated research with HMORN sites. The VDW has been 
successfully implemented on a variety of platforms, including Teradata®, 
SQL Server®, Oracle®, and SAS® data sets in Windows® and UNIX®, while 
allowing interoperability and distributed querying. In practice, VDW 
data extraction is performed using SAS, so accessibility via SAS is an 
important consideration in site implementation configuration. 
Appendix A provides a partial list of the hundreds of peer-reviewed 
journal articles that have used data extracted from the VDW organized 
by network consortia. Examples from recent studies using the VDW in-
clude the CRN’s finding that the increased use of computed tomography 
in the pediatric population has resulted in children receiving high doses 
of radiation known to cause cancer.32 The MHRN, based on health care 
utilization and mortality data from the VDW, concluded that there is 
great opportunity for suicide prevention through targeted improvements 
in primary care.33 Also using the VDW, the Cardiovascular Research 
Network identified increased risk of death and hospitalization associated 
with chronic kidney disease among adults with heart failure.34 Several 
HMORN sites use the VDW as a major source for nearly all quantitative 
research conducted, even if not part of a multisite network consortium 
like those listed above. The VDW’s widespread use in assessing study 
feasibility, conducting multisite research, and conducting single site 
research across a diverse set of subject matters and disciplines is among 
its greatest strengths.
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An entity-relationship (ER) model depicting the HMO Research Network Virtual Data Warehouse as it existed in 2014.
Figure 3 – The HMORN Virtual Data Warehouse Data Model
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Discussion
Over the past decade, the HMORN VDW has grown in breadth, 
depth, quality, and use. The VDW has been used to support the 
work of hundreds of research investigators and hundreds of pub-
lications. The VDW approach to multicenter research has been 
successfully adopted by several large-scale multisite networks. At 
the same time, VDW data sources such as EHRs and health plan 
data systems have grown and matured, expanding data available 
for research within the VDW. 
While public domain research is valued by HMORN member 
health systems, the designs of internal IT systems are driven by 
health care operational priorities, not research. For example, 
despite their significance in care delivery and research, data on 
patient race and ethnicity were rarely collected in structured EHR 
data until required by meaningful use incentives put in place by 
the Centers for Medicare & Medicaid Services. Adherence to the 
VDW principle of flexibility and extensibility has been paramount 
to the continuation of the VDW data model in a rapidly changing 
health information technology environment. The changing health 
care environment means that the VDW maintenance, quality 
improvement, and enhancement require ongoing support and vig-
ilance. The VDW governance and support structure that includes 
the VOC, VIG, workgroups, and Asset Stewardship Committee 
play a crucial role in the continued value and use of the VDW. 
The VDW is not without its limitations. Foremost is that data in 
the model are limited to information acquired and preserved by 
sites in the course of business and care delivery. This limitation 
exists for any research data model sourced by claims and EHR 
data. Researchers who use this type of data sometimes incorrectly 
assume that the presence of variables in the data model implies 
that those variables are populated at every site over all time; 
users are advised to ensure the availability of the data they need 
in a study feasibility assessment. The issue of data availability is 
increasingly important as nonintegrated health care systems adopt 
the VDW model, and traditional integrated health plan and care 
delivery models are supplemented with contracts to clinicians 
who provide care to health system members but do not use the 
system’s EHR. A business decision by a health care system to 
contract out specialty care services, for example, may limit or even 
terminate the availability of specialty care data at a site. Health 
information exchanges, which increase health care provider access 
to patient electronic medical information, have the potential to 
mitigate data availability problems, but only to the extent that ex-
changed information is available to researchers. The limitation of 
data availability by site stresses the importance of site documenta-
tion and project-specific quality assurance analysis, both of which 
are strongly encouraged by the VOC.
A second limitation is that implementing and maintaining a 
multicenter data resource requires substantial resources. These 
costs are not unique to the VDW; all multicenter research projects 
will face costs associated with data standardization and curation. 
In the case of the VDW, we have found that this investment pays 
dividends with each use, but requires a certain level of use to 
reach a break-even point. Costs of maintenance includes costs 
associated with ongoing data quality review, source system alter-
ations, VDW specification changes and identification of variation 
in implementation across sites. Ongoing maintenance and sup-
port of a multicenter research warehouse like the VDW requires 
a stable funding mechanism that should be supported by the 
participating institutions and the individual users of the resource. 
Monitoring the use of a data resource like the VDW within a 
distributed network is challenging and is an important area for 
improvement; better tracking of VDW usage would improve 
future usability and enable identification of best practices.
A third limitation is that some differences in data across sites 
cannot be resolved through a standardized data model. While 
VDW data reflect substantial efforts to abstract away data and 
system differences across sites, their use without knowledge of 
local source systems and health care policies and practices can 
lead to dubious conclusions. Using and interpreting VDW data 
correctly requires extensive knowledge of the health care and IT 
systems from which VDW data are sourced. Including local staff 
from each data-contributing site on the research team greatly 
facilitates data quality checks and interpretation of site-specific 
data patterns. For example, durable medical equipment can be 
dispensed through the pharmacy or delivered through an outside 
contract vendor. Chemotherapy infusion treatment may be doc-
umented through pharmacy dispensings or through procedural 
billing codes.35 These different methods of delivering care and 
paying for it will be reflected differently in VDW data at each site. 
Site representation when designing a study, extracting data, and 
analyzing results prevents erroneous conclusions.
The VDW continues to adapt to a changing health care and health 
IT environment. The VDW’s historic dependence on SAS is 
waning as sites increasingly use relational databases to store VDW 
data and developers build non-SAS-dependent query tools that 
access VDW data. New data subject areas under consideration 
include patient-reported outcomes, dental care, infusion therapy, 
genetic sequencing, clinical text, physician ordering and linkages 
to birth certificate data. Which subject areas are developed will be 
driven by the needs of research projects making use of the VDW 
in the coming years.
Next Steps for the Community
The VDW data model can be emulated by health care and health 
insurance systems outside the HMORN who are seeking to 
implement a distributed interoperable health care data system or 
develop collaborations with the HMORN. We welcome requests 
for technical assistance from external health care delivery systems 
and health researchers interested in becoming part of this large 
data cooperative. Moreover, the VDW governance welcomes sug-
gestions for improvements, expansions, and collaborations.
The HMORN VDW is an evolving and extensible data model 
because of its ability to include new content and develop new 
definitions of existing data fields. The VDW is sustainable because 
it increases efficiency and usability of health care informatics 
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resources by eliminating duplicative data programming and en-
abling software and tools that make use of data.
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Appendix A
A list of online databases containing publications from consortia 
that have used the HMORN Virtual Data Warehouse as a major 
source of their quantitative data.
http://crn.cancer.gov/publications
http://cvrn.org/projects/publications/index.aspx
http://www.supreme-dm.org/Publications.html
http://span-network.org/Publications.html
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